Farmak
VC Fund
Kyiv, Ukraine
Farmak is a Ukraine-based pharmaceutical company that creates and manufactures medical drugs. Since 2010, Farmak is the leader of the pharmaceutical market of Ukraine and the largest exporter of medicines. The company has 20 production lines that meet GMP requirements. Since 2015, JSC "Farmak" has its own complex for the manufacture ofsubstances (Department of Production of API) in Shostka, the planned capacity of which is 100 tons of substances per year.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Farmak invests in
Stages Farmak invests in
Countries Farmak invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1M–$1.6M
Investment Focus
Industry
- Health Care 3 (60%)
- Medical 2 (40%)
- Mobile 1 (20%)
- Hospital 1 (20%)
- Education 1 (20%)
Stage
- Seed 2 (40%)
- Funding Round 2 (40%)
- Pre-Seed 1 (20%)
Country
- Ukraine 2 (40%)
- Estonia 1 (20%)
- United States 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Altris.AI
|
Altris.AI is a MedTech company that uses AI to set higher diagnostics standards and improve patient outcomes as a result. Altris AI uses the most extensive dataset of ophthalmic images and an advanced algorithm that recognizes 70+ retina pathologies and biomarkers on OCT scans. | $1M / Dec 14, 2022 | |
|
Altris.AI
|
Altris.AI is a MedTech company that uses AI to set higher diagnostics standards and improve patient outcomes as a result. Altris AI uses the most extensive dataset of ophthalmic images and an advanced algorithm that recognizes 70+ retina pathologies and biomarkers on OCT scans. | $1M / Seed / Dec 14, 2022 | |
DrugCards
|
DrugCard offers a low-cost full-regulatory compliant software solution designed for drug safety departments to automate medical literature monitoring. | $288K / Pre-Seed / Dec 09, 2021 | |
ComeBack Mobility
|
ComeBack Mobility provides wireless devices, attached to crutches, to monitor a patient’s walking recovery progress. ComeBack Mobility has developed smart crutch tips to control the load on the injured leg, combining AI with a simple hardware product. Smart crutch tips send data to a mobile app and compare the data to the doctor’s recommendation.The app then gives feedback to the patient. | $1.6M / Seed / Jun 18, 2021 | |
Bicovery
|
Bicovery is a Med-tech solution that helps people with Bipolar Disorder. Bicovery monitors patients' physical and mental state in real-time. It defines itself as “an ecosystem with web and mobile applications, which helps a person with bipolar disorder.” Relatives and doctors receive “more complete information about the dynamics of the diseaseas well as warnings about potential manic or depressive episodes.” The Bicovery solution is also used to “measure the efficacy of medicinal products and procedures; reduce the cost and increase the systemic treatment; and improve the quality of life of the patient and his/her relatives.” | Dec 09, 2020 |
Co-Investors
Artesian VC
2 deals together
The University of Chicago Booth School of Business
2 deals together
Brinc
2 deals together
Chicago Booth Angels
2 deals together
JOINT JOURNEY
2 deals together
Runa Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Farmak invest in?
Farmak invests primarily in Health Care, Medical and Mobile startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Ukraine. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Farmak's check size?
Farmak typically joins rounds of $1M–$1.6M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Farmak participates in.
How do I contact Farmak?
Public channels for Farmak include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Farmak?
The team at Farmak includes Volodymyr Kostiuk (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
